Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon

Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)

  • Report Code : 1013049
  • Industry : Services
  • Published On : Jan 2024
  • Pages : 260
  • Publisher : Azoth Analytics
  • Format: WMR PPT FormatWMR PDF Format

Executive Summary

Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, estimates of 2023 and the forecast for 2024-2029.

The Global Cell and Gene Therapy CDMO market valued at USD 2.54 billion in 2022 is expected to grow at a CAGR of 30.75% during the forecast period of 2024-2029. The global Cell and Gene Therapy CDMO market has been experiencing robust growth and escalating demand, propelled by continuous advancements in cell and gene therapies. With a broadening scope of therapeutic areas and a favourable regulatory environment, the global Cell and Gene Therapy CDMO market is poised for sustained expansion as it plays a pivotal role in the development and commercialization of ground-breaking therapies for various diseases. The global Cell and Gene Therapy CDMO market is expected to grow at an extraordinary rate driven by significant investments from industry players.

The global pipeline of cell and gene therapies has been expanding, covering a wide range of therapeutic areas, including oncology, rare diseases, and genetic disorders. As more therapies advance through clinical trials and toward commercialization, the demand for CDMO services for manufacturing, process development, and scale-up increases.

Global CDMO organisations for cell and gene therapy are expanding, and this is one of the main factors propelling the global Cell and Gene Therapy's overall expansion. With the increasing global demand for advanced cell and gene therapies, CDMOs are proactively setting up production facilities in various locations to meet the changing demands of biotechnology and pharmaceutical companies. These days, CDMOs are essential to the manufacturing of pharmaceuticals. Over the past ten years, CDMOs have grown in prominence due to a more dynamic mergers and acquisition landscape. Serving both local and international markets, there are currently over 600 active Contract Development and Manufacturing Organizations (CDMOs). CDMOs provide specific expertise that helps both "Big Pharma" and smaller inventors to launch products sooner.

The rise of biologics is seen by the number of CDMOs making significant investments in brand-new biomanufacturing facilities. These companies include Boehringer Ingelheim (USD827M investment), Samsung Biologics (USD1.7B investment), Lonza (USD935M expansion), and Fujifilm Diosynth Biotechnologies (USD2B investment).

Additionally, by expanding globally, CDMOs can meet regional regulatory needs, provide customised manufacturing solutions, and improve accessibility for customers who need their services. CDMOs can provide more adaptable and responsive solutions by being present in important worldwide markets. This helps to speed up the development and global commercialization of gene and cell therapies.

One prominent factor restraining the growth of the global Cell and Gene Therapy CDMO market is the high cost of producing viral vectors. As carriers of therapeutic genes into target cells, viral vectors are essential to the development of gene and cell therapies. Viral vector production is a complex procedure that frequently involves specialized techniques, stringent quality control standards, and specialized facilities.

There are now five viral vectors in use for gene therapy. AAV have the biggest market share, followed by lentiviruses, adenoviruses, herpes simplex viruses and retroviruses. The vector manufacturing cost for a single dose might be as high as USD 1-2 million, given the expected price of USD 3-7 million per batch, according to Roland Berger Insights. Therefore, the high cost of producing viral vectors hampers cell and gene therapies from being widely commercialised and made accessible, which limits their uptake and hinders the expansion of the Cell and Gene CDMO market.



Scope of the Report

• The report analyses the Global Cell and Gene Therapy CDMO Market by Value (USD Million).

• The report presents the analysis of Global Cell and Gene Therapy CDMO Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Global Cell and Gene Therapy CDMO Market by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies).

• The report analyses the Cell and Gene Therapy CDMO Market by Application (Clinical, Pre-clinical).

• The report analyses the Cell and Gene Therapy CDMO Market by Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Other Indications).

• The report analyses the Cell and Gene Therapy CDMO Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa).

• The report analyses the Cell and Gene Therapy CDMO Market by Country (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, South Korea, India).

• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis.

• Also, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Oxford Biomedica, Lonza Group AG, Catalent, Inc., Samsung Biologics, WuXi Biologics, Pfizer CentreOne, Danaher Corporation, Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Novartis AG.

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

3. Global Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)

3.1 Impact Analysis of Macro Economic Factors on Cell and Gene Therapy CDMO Market

3.2 Cell and Gene Therapy Pipeline

3.3 Clinical AAV Gene Therapies

3.4 Approvals & Drugs by Therapy Area

3.5 Approved Therapies and Pipeline

3.6 Gene Therapy Pipeline

3.7 Gene Therapy Breakdown

3.8 Gene Therapy Pipeline: Most Commonly Targeted Therapeutic Areas

3.9 Cell and Gene Therapy Landscape

3.10 Global Cell and Gene Therapy CDMO Market: Dashboard

3.11 Global Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million)

3.12 Global Cell and Gene Therapy CDMO Market: Recent Development & Approved Cell and Gene Therapies

3.13 Global Cell and Gene Therapy CDMO Market: Recent M&A and Developments

3.14 Impact of COVID-19 on Cell and Gene Therapy CDMO Market

3.15 Global Cell and Gene Therapy CDMO Market Segmentation: By Type

3.15.1 Global Cell and Gene Therapy CDMO Market, By Type Overview

3.15.2 Global Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)

3.15.3 Global Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)

3.15.4 Global Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)

3.16 Global Cell and Gene Therapy CDMO Market Segmentation: By Application

3.16.1 Global Cell and Gene Therapy CDMO Market, By Application Overview

3.16.2 Global Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)

3.16.3 Global Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)

3.17 Global Cell and Gene Therapy CDMO Market Segmentation: By Indication

3.17.1 Global Cell and Gene Therapy CDMO Market, By Indication Overview

3.17.2 Global Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)

3.17.3 Global Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)

3.17.4 Global Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)

3.17.5 Global Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Cell and Gene Therapy CDMO Market: Regional Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot

5. Americas Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)

5.1 Americas Cell and Gene Therapy CDMO Market: Snapshot

5.2 Americas Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)

5.3 Americas Cell and Gene Therapy CDMO Market: Key Factors

5.4 Americas Cell and Gene Therapy CDMO Market: Segment Analysis

5.5 Americas Cell and Gene Therapy CDMO Market Segmentation: By Type

5.5.1 Americas Cell and Gene Therapy CDMO Market, By Type Overview

5.5.2 Americas Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)

5.5.3 Americas Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)

5.5.4 Americas Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)

5.6 Americas Cell and Gene Therapy CDMO Market Segmentation: By Application

5.6.1 Americas Cell and Gene Therapy CDMO Market, By Application Overview

5.6.2 Americas Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)

5.6.3 Americas Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)

5.7 Americas Cell and Gene Therapy CDMO Market Segmentation: By Indication

5.7.1 Americas Cell and Gene Therapy CDMO Market, By Indication Overview

5.7.2 Americas Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)

5.7.3 Americas Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)

5.7.4 Americas Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)

5.7.5 Americas Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)

5.8 Americas Cell and Gene Therapy CDMO Market Segmentation: By Country

5.8.1 Americas Cell and Gene Therapy CDMO Market, By Country Overview

5.8.2 United States Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.2.1 United States Cell and Gene Therapy CDMO Market, By Type

5.8.2.2 United States Cell and Gene Therapy CDMO Market, By Application

5.8.2.3 United States Cell and Gene Therapy CDMO Market, By Indication

5.8.3 Canada Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.3.1 Canada Cell and Gene Therapy CDMO Market, By Type

5.8.3.2 Canada Cell and Gene Therapy CDMO Market, By Application

5.8.3.3 Canada Cell and Gene Therapy CDMO Market, By Indication

5.8.4 Rest of Americas Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.4.1 Rest of Americas Cell and Gene Therapy CDMO Market, By Type

5.8.4.2 Rest of Americas Cell and Gene Therapy CDMO Market, By Application

5.8.4.3 Rest of Americas Cell and Gene Therapy CDMO Market, By Indication

6. Europe Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)

6.1 Europe Cell and Gene Therapy CDMO Market: Snapshot

6.2 Europe Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)

6.3 Europe Cell and Gene Therapy CDMO Market: Key Factors

6.4 Europe Cell and Gene Therapy CDMO Market: Segment Analysis

6.5 Europe Cell and Gene Therapy CDMO Market Segmentation: By Type

6.5.1 Europe Cell and Gene Therapy CDMO Market, By Type Overview

6.5.2 Europe Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)

6.5.3 Europe Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)

6.5.4 Europe Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Cell and Gene Therapy CDMO Market Segmentation: By Application

6.6.1 Europe Cell and Gene Therapy CDMO Market, By Application Overview

6.6.2 Europe Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Cell and Gene Therapy CDMO Market Segmentation: By Indication

6.7.1 Europe Cell and Gene Therapy CDMO Market, By Indication Overview

6.7.2 Europe Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)

6.7.3 Europe Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)

6.7.4 Europe Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)

6.7.5 Europe Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)

6.8 Europe Cell and Gene Therapy CDMO Market Segmentation: By Country

6.8.1 Europe Cell and Gene Therapy CDMO Market, By Country Overview

6.8.2 United Kingdom Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.2.1 United Kingdom Cell and Gene Therapy CDMO Market, By Type

6.8.2.2 United Kingdom Cell and Gene Therapy CDMO Market, By Application

6.8.2.3 United Kingdom Cell and Gene Therapy CDMO Market, By Indication

6.8.3 Germany Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.3.1 Germany Cell and Gene Therapy CDMO Market, By Type

6.8.3.2 Germany Cell and Gene Therapy CDMO Market, By Application

6.8.3.3 Germany Cell and Gene Therapy CDMO Market, By Indication

6.8.4 France Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.4.1 France Cell and Gene Therapy CDMO Market, By Type

6.8.4.2 France Cell and Gene Therapy CDMO Market, By Application

6.8.4.3 France Cell and Gene Therapy CDMO Market, By Indication

6.8.5 Italy Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.5.1 Italy Cell and Gene Therapy CDMO Market, By Type

6.8.5.2 Italy Cell and Gene Therapy CDMO Market, By Application

6.8.5.3 Italy Cell and Gene Therapy CDMO Market, By Indication

6.8.6 Rest of Europe Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.6.1 Rest of Europe Cell and Gene Therapy CDMO Market, By Type

6.8.6.2 Rest of Europe Cell and Gene Therapy CDMO Market, By Application

6.8.6.3 Rest of Europe Cell and Gene Therapy CDMO Market, By Indication

7. Asia Pacific Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)

7.1 Asia Pacific Cell and Gene Therapy CDMO Market: Snapshot

7.2 Asia Pacific Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)

7.3 Asia Pacific Cell and Gene Therapy CDMO Market: Key Factors

7.4 Asia Pacific Cell and Gene Therapy CDMO Market: Segment Analysis

7.5 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Type

7.5.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Type Overview

7.5.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)

7.5.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)

7.5.4 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)

7.6 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Application

7.6.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Application Overview

7.6.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)

7.6.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)

7.7 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Indication

7.7.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Indication Overview

7.7.2 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)

7.7.3 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)

7.7.4 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)

7.7.5 Asia Pacific Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)

7.8 Asia Pacific Cell and Gene Therapy CDMO Market Segmentation: By Country

7.8.1 Asia Pacific Cell and Gene Therapy CDMO Market, By Country Overview

7.8.2 China Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.2.1 China Cell and Gene Therapy CDMO Market, By Type

7.8.2.2 China Cell and Gene Therapy CDMO Market, By Application

7.8.2.3 China Cell and Gene Therapy CDMO Market, By Indication

7.8.3 Japan Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.3.1 Japan Cell and Gene Therapy CDMO Market, By Type

7.8.3.2 Japan Cell and Gene Therapy CDMO Market, By Application

7.8.3.3 Japan Cell and Gene Therapy CDMO Market, By Indication

7.8.4 South Korea Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.4.1 South Korea Cell and Gene Therapy CDMO Market, By Type

7.8.4.2 South Korea Cell and Gene Therapy CDMO Market, By Application

7.8.4.3 South Korea Cell and Gene Therapy CDMO Market, By Indication

7.8.5 India Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.5.1 India Cell and Gene Therapy CDMO Market, By Type

7.8.5.2 India Cell and Gene Therapy CDMO Market, By Application

7.8.5.3 India Cell and Gene Therapy CDMO Market, By Indication

7.8.6 Rest of Asia Pacific Cell and Gene Therapy CDMO Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.7.1 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Type

7.8.7.2 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Application

7.8.7.3 Rest of Asia Pacific Cell and Gene Therapy CDMO Market, By Indication

8. Middle East & Africa Cell and Gene Therapy CDMO Market: Historic and Forecast (2019-2029)

8.1 Middle East & Africa Cell and Gene Therapy CDMO Market: Snapshot

8.2 Middle East & Africa Cell and Gene Therapy CDMO Market: Market Value Assessment, 2019-2029 (USD Million & CAGR)

8.3 Middle East & Africa Cell and Gene Therapy CDMO Market: Key Factors

8.4 Middle East & Africa Cell and Gene Therapy CDMO Market: Segment Analysis

8.5 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Type

8.5.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Type Overview

8.5.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Cell Therapy, By Value, 2019H-2029F (USD Million & CAGR)

8.5.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Gene Therapy, By Value, 2019H-2029F (USD Million & CAGR)

8.5.4 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Gene-modified Cell Therapies, By Value, 2019H-2029F (USD Million & CAGR)

8.6 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Application

8.6.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Application Overview

8.6.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Clinical, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Pre-clinical, By Value, 2019H-2029F (USD Million & CAGR)

8.7 Middle East & Africa Cell and Gene Therapy CDMO Market Segmentation: By Indication

8.7.1 Middle East & Africa Cell and Gene Therapy CDMO Market, By Indication Overview

8.7.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Oncology Diseases, By Value, 2019H-2029F (USD Million & CAGR)

8.7.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Infectious Diseases, By Value, 2019H-2029F (USD Million & CAGR)

8.7.4 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Neurological Disorder, By Value, 2019H-2029F (USD Million & CAGR)

8.7.5 Middle East & Africa Cell and Gene Therapy CDMO Market Size, By Other Indications, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Cell and Gene Therapy CDMO Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Industry Ecosystem Analysis

10.1 Value Chain Analysis

10.2 Porter's Five Forces Model

11. Competitive Positioning

11.1 Companies' Product Positioning

11.2 Competitive Positioning of Oxford Biomedica's Viral Vector Offering

11.3 Market Position Matrix

11.4 Market Share Analysis of Cell and Gene Therapy CDMO Market

11.5 Company Profiles

11.5.1 Oxford Biomedica

11.5.2 Lonza Group AG

11.5.3 Catalent, Inc.

11.5.4 Samsung Biologics

11.5.5 WuXi Biologics

11.5.6 Pfizer CentreOne

11.5.7 Danaher Corporation

11.5.8 Thermo Fisher Scientific Inc.

11.5.9 Charles River Laboratories International, Inc.

11.5.10 Novartis AG

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

CRISPR Cell Line Development Market Size And Share Analysis - Growth Trends And Forecasts (2024...
View More
Gene Knockdown Stable Cell Line Service Market Size And Share Analysis - Growth Trends And Fore...
View More
Cell Line Customization Service Market Size And Share Analysis - Growth Trends And Forecasts (2...
View More
Gene Knockdown Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)
View More
Cell Line Adaptation Service Market Size And Share Analysis - Growth Trends And Forecasts (2024...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved